Keywords = DAAs
| Number of Articles: 28 | ||||
| 1 | Impact of Direct-Acting Antivirals on Recurrence of Hepatocellular Carcinoma after Curative Treatment. | |||
| Volume 27, Issue 3, 2023, Page 64-77 | ||||
| Mahmoud Kamal Elsamman; Ahmed Othman Abodooh; Ali Mahmoud Kassem; Amal Khalifa Noreldin | ||||
| 2 | Biochemical study on the response to HCV therapy (Velpatasvir containing regimen), (vosevi) among adult patients’ non-responders to treatment in Fayoum Egypt | |||
| Volume 46, Issue 2, April 2023, Page 123-134 | ||||
| Hasnaa Sayed Kamal; Nancy Abdalla Atta; Naglaa Rifaat Ismael; Heba Ahmed Aldash; Ahmed Ali Gomaa | ||||
| 3 | Assessment of Incidence of Hepatocellular Carcinoma among Hepatitis C Patients Who Achieved Sustained Virological Response with Direct Acting Antiviral Agents (DAAs) | |||
| Volume 91, Issue 1, April 2023, Page 5276-5283 | ||||
| Ibrahim M. Ibrahim; Mohammed Emam Farghaly; Ahmed Embaby; Dina Gamal Abdallah Abdelrahman; Mona Ahmed Abdelmaksoud | ||||
| 4 | Long-term Follow-up of Chronic Hepatitis C Patients Treated by Direct- Acting Antivirals | |||
| Volume 90, Issue 2, January 2023, Page 2767-2774 | ||||
| Ahmed Tawheed; Mohamed El-Kassas; Amr El-Fouly; Gamal Esmat | ||||
| 5 | Direct Acting Antiviral Drugs: Pharmacokinetics and Drug-Drug Interactions | |||
| Volume 6, Issue 2, December 2022, Page 274-291 | ||||
| Marina Barakat; Sara Wahdan; Azza Awad; Ebtehal El-Demerdash Zaki | ||||
| 6 | EVALUATION OF THE SAFETY AND RESISTANCE ASSOCIATED VARIANTS OF SOFOSBUVIR/DACLATASVIR AMONG EGYPTIAN PATIENTS WITH HEPATITIS C VIRUS: A PROSPECTIVE STUDY | |||
| Volume 45, Issue 2, December 2022, Page 1143-1153 | ||||
| Haidi Karam -Allah Ramadan; , Soha Saoud Abdel-Monem; Ahlam Mohamed Ahmed; Rasha Maree Omar; Hala Rady Ahmed; Helal F. Hetta | ||||
| 7 | SAFETY AND EFFICACY OF DIRECTLY ACTING ANTIVIRAL DRUGS IN TREATMENT OF CHRONIC HCV EGYPTIAN PATIENTS | |||
| Volume 52, Issue 3, December 2022, Page 413-424 | ||||
| HEBA MOHAMED ABDELLA; ASHRAF MOHAMMAD EL BREEDY; AMIRA MAHMOUD AL-BALAKOSY; GHADA ASSEM MOHAMED HEGAZY; MOHAMED MAHMOUD EL KASSAS | ||||
| 8 | Lymphoid Malignancies and Direct-Acting Antivirals: Review Article | |||
| Volume 89, Issue 1, October 2022, Page 4540-4543 | ||||
| walaa gamal soliman; Amr Mohamed Zaghloul; Ali Mohammed Ali; Mohamed Soliman Gaber | ||||
| 9 | Combined Sofosbuvir/Daclatasvir and Chemotherapy Markedly Improve The Outcome of B-Lymphoid Malignancies in Patients with Both HCV Infection and B-Lymphoid Malignancy | |||
| Volume 89, Issue 1, October 2022, Page 4676-4684 | ||||
| walaa gamal soliman; Amr Mohamed Zaghloul; Ali Mohammed Ali; Mohamed Soliman Gaber | ||||
| 10 | Safety and Efficacy of Sofosbuvir Based Regimens in the Treatment of HCV Recurrence Post Liver Transplantation | |||
| Volume 87, Issue 1, April 2022, Page 973-978 | ||||
| Mohamed Abbasy; Mohamed Ahmed Afifi; Eman Abd El-Sameea Mahmoud; Tary Abd El-Hamid Salman; Eman Ahmed Rewisha; OmKolsoum Mohamed Al Haddad; Talaat Zakareya Ibrahim | ||||
| 11 | Pattern of Response to Sofosbuvir and Daclatasvir +/- Ribavirin Regimen in Chronic Hepatitis C Patients | |||
| Volume 87, Issue 1, April 2022, Page 2057-2063 | ||||
| Reem M. Abd El Hamed; Ghada M. Galal; Nagwa S. Ahmed; Mahmoud Saif Al-Islam | ||||
| 12 | Assessment of Fibrosis After Treatment with Direct-Acting Antiviral Drugs with or without Silymarin in Patients with Chronic Hepatitis C Related Liver Disease | |||
| Volume 3, Issue 1, 2021, Page 1-11 | ||||
| 13 | RECURRENCE RATE OF HEPATOCELLULAR CARCINOMA AFTER TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH DIRECT ACTING ANTIVIRALS: RANDOMIZED CONTROLLED PHASE 3 TRIAL. PRELIMINARY RESULTS | |||
| Volume 72, Issue 4, December 2021, Page 701-713 | ||||
| Fatma Sayed Mohamed Abdelbakey; Hesham Ahmed Elghazaly; Mohamed Kamal Shaker; Nagi Samy Gobran; Khaled Naguib Abdelhakim; Reham Mohamed Faheim | ||||
| 14 | Musculoskeletal Manifestations and Bone Mineral Density in Chronic Hepatitis C Patients | |||
| Volume 38, Issue 3, November and December 2021, Page 848-864 | ||||
| samy Egela; Yasser Abed El- Aziz Abed El-Hamid; tamer eleraky elazab; Basma Goda El sayed; marwa mahgoub | ||||
| 15 | Effect of DAAs on improvement of liver fibrosis assessed by transiet elastography and associated risk factors for accelerating liver fibrosis | |||
| Volume 38, Issue 3, November and December 2021, Page 972-983 | ||||
| Mostafa El-Kady; Medhat El-Sahhar; Tamer El-Azab; Abdel rahman Ali | ||||
| 16 | Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis After Treatment with Direct Acting Antiviral Therapy | |||
| Volume 6, Issue 4, August 2021, Page 243-248 | ||||
| M.S. El-Kady; N.E. El-Toukhy; M.S. Abd El-Wahhab | ||||
| 17 | Detecting Imaging For Neoplastic Liver Masses in Hepatic Patients Who Received Direct Acting Antiviral Drugs | |||
| Volume 38, Issue 2, July 2021, Page 657-670 | ||||
| Medhat Refat; Osama Galal; Shaimaa taha | ||||
| 18 | Impact of Hepatitis C virus Infection and direct-acting Oral Antiviral Drugs on glycaemic state in Type 2 Diabetic Patients | |||
| Volume 38, Issue 1, April 2021, Page 185-195 | ||||
| Ayman ElBadawy; Mohamed ElSayed; Islam Abdullatif; Rasha AbdelMoneim | ||||
| 19 | Effect of Direct Acting Anti-Hepatitis C Drugs on the Heart | |||
| Volume 82, Issue 1, January 2021, Page 106-114 | ||||
| Mohamed Mahmoud Ahmed; Muhammad Abdel-Gawad; Mahmoud Ahmed Abd elbaset; Assem Elkady | ||||
| 20 | Evaluation of IL28B Gene Sequence Variations in the Diagnosed Null-Response to DAAs Therapy by Intra PBMCs Nested HCV RNA PCR | |||
| Volume 1, Issue 11, November 2020, Page 168-173 | ||||
| Mohamed Darwish Ahmed Abd Alla; ahmed mohammed altambouly; Mohamed Darwish Ahmed Abd Alla; Galal AbdElhameed AbuFarrag; Islam Abdel-Mawla Ammar; Mostafa Kamel El-Awady | ||||
| 21 | Outcome of Direct Acting Antiviral Drugs (DAADs) for Hepatitis C Virus (HCV) in the Setting of Chronic Kidney Disease (CKD) in Upper Egypt | |||
| Volume 81, Issue 5, October 2020, Page 2012-2015 | ||||
| Iman Ibrahim Sarhan; Mohamed Mostafa Ali; Ahmed Abd Elmonem Hassan; Mostafa Abd Elnasier Abd Elgawad | ||||
| 22 | A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs | |||
| Volume 1, Issue 9, September 2020, Page 256-260 | ||||
| Moataz Mostafa Mousa; Magdy A. Elkerim El Dahshan; Arafat A. Elazem Qasem; Wael Refaat Hablas | ||||
| 23 | Cost-Effectiveness of HCV Core Antigen versus PCR for Monitoring Treatment Response in DAAS-Treated Egyptian Patients | |||
| Volume 10, Issue 2, June 2020, Page 174-182 | ||||
| Mohammed Alaa EL-Din Nouh; Mohamed Gamal Elhelbawy; Mohammed Abdel Badie Mohammed Soliman; Ahmed Ragab El-Gazzarah | ||||
| 24 | Effect of HCV Eradication on Glycemic Control of Type 2 Diabetes Mellitus | |||
| Volume 79, Issue 1, April 2020, Page 548-552 | ||||
| Islam Ahmed Mohamed Sayed; Faried Fawzy Abd-elHafez; Hatem Mahmoud Salem | ||||
| 25 | Hepatitis C Virus Treatment Update | |||
| Volume 24, Issue 1, January 2020, Page 79-85 | ||||
| mona mohammed abd el rhman; Ghada Moustafa Moustafa Galal; Ramy Mamdouh Abd El Hamid; Safaa Khalaf Abd Allah | ||||
| | ||||
View on SCiNiTO
